Loading...
Nordic Life Science 1
BUSINESS Q & A IN FOCUS RESTORING BLOOD FLOW SWED
ISH DRUG DEVELOPMENT COMPANY MODUS THERAPEUTICS HAS HAD A BUSY YEAR, AND 2019 COULD TAKE THEM ONE STEP CLOSER TO HAVING SEVUPARIN ON THE MARKET. T E X T B Y MA L I N O T MAN I